Article text
Back to course
Pdf Summary
Keywords
Spinal muscular atrophy
lower motor neuron disease
SMN1
nusinersen
gene replacement therapy
risdiplam
efficacy
safety profiles
treatment selection
optimal outcomes
SMA


2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

                   

© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
Powered By